Marc Mansour's Avatar

Marc Mansour

@marcmansour.bsky.social

Professor of Haematology at University College London Cancer Institute and Great Ormond Street Institute of Child Health. Clinician scientist investigating, caring for and developing new therapies for patients with acute leukaemia

236 Followers  |  311 Following  |  4 Posts  |  Joined: 06.01.2025  |  1.4605

Latest posts by marcmansour.bsky.social on Bluesky

Congrats @floriangrebien.bsky.social and team for this great paper!

28.11.2025 13:58 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0
Post image

🧬 New strategy to fight #AML: A study led by @floriangrebien.bsky.social & team at Vetmeduni, @stanna-ccri.bsky.social & CeMM identified the protein SPOP as a direct regulator of the stability of NUP98 fusion oncoproteins, a potential target for new therapies.

➑️ bit.ly/3M2RfWz
πŸ“„ bit.ly/4omtZ3x

28.11.2025 07:30 β€” πŸ‘ 4    πŸ” 4    πŸ’¬ 0    πŸ“Œ 1
Preview
Human RPA is an essential telomerase processivity factor for maintaining telomeres Telomerase counteracts telomere shortening by repeatedly adding DNA repeats to chromosome ends. We identified the replication protein A (RPA) heterotrimer as a telomerase processivity factor critical ...

Our paper in Science is out! @souravagrawal.bsky.social, @rlynn.bsky.social, @susvirkar.bsky.social, and the rest of the team show human RPA is a telomerase processivity factor essential for telomere maintenance. This reshapes our thinking about telomerase regulation. www.science.org/doi/10.1126/...

30.10.2025 22:07 β€” πŸ‘ 122    πŸ” 41    πŸ’¬ 10    πŸ“Œ 5
Preview
Canagliflozin synergises with serine restriction mediating anti-leukaemic effects in T-cell acute lymphoblastic leukaemia T-cell acute lymphoblastic leukaemia (T-ALL) is a haematological malignancy commonly driven by NOTCH1 activating mutations. A concomitant feature asso…

Really pleased to share the labs first publication in paediatric T-cell leukaemia. We find that the type 2 diabetes drug canagliflozin possesses anti-leukaemic effects that can be enhanced via dietary restriction of serine.

www.sciencedirect.com/science/arti...

21.10.2025 09:37 β€” πŸ‘ 11    πŸ” 4    πŸ’¬ 1    πŸ“Œ 1

Bye bye X, hello Bluesky !

13.09.2025 12:56 β€” πŸ‘ 8    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

This is not a HiC map! Ever wondered if multiple enhancers get activated simultaneously? We measured chromatin accessibility on thousands of molecules by nanopore to create genome-wide co-accessibility maps. Proud of @mathias-boulanger.bsky.social @kasitc.bsky.social Biology in the threadπŸ‘‡

18.08.2025 13:00 β€” πŸ‘ 113    πŸ” 34    πŸ’¬ 10    πŸ“Œ 0

Congrats to Kira Young who spearheaded this work & all contributing authors. This was a fun (and long!) collaboration with @marcmansour.bsky.social, @challenlab.bsky.social, @ericpietras.bsky.social, Kelsey Fisher-Wellman, @keisukeito-lab.bsky.social & Steven Chan

16.04.2025 21:02 β€” πŸ‘ 5    πŸ” 2    πŸ’¬ 1    πŸ“Œ 0

Thanks Sunniyat - great to be part of the Bluesky community- like a breath of fresh air !

09.01.2025 23:12 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

This is fantastic mechanistic work Dorien, Ruud and team! Congrats

08.01.2025 00:26 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0
Video thumbnail

For my new followers! Focal deletions of noncoding regions in cancer genomes can have unexpected consequences. Out now in @bloodjournal.bsky.social, we’ve discovered a novel mechanism of oncogene activation whereby focal deletion of a β€˜promoter tether’ leads to aberrant expression of IRX3 in T-ALL.πŸ‘‡

10.12.2024 10:34 β€” πŸ‘ 16    πŸ” 5    πŸ’¬ 2    πŸ“Œ 2

@marcmansour is following 20 prominent accounts